Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Advances in Experimental Medicine and Biology|January 5, 2010
Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine designThomas Ebensen, Carlos A Guzmán
The Open Microbiology Journal|May 28, 2009
The toll-like receptor 2/6 ligand MALP-2 reduces the viability of Mycobacterium tuberculosis in murine macrophagesCarla Palma, Elisabetta Iona, Thomas Ebensen, et al.
Frontiers in Cellular and Infection Microbiology|March 7, 2019
The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post ImmunizationThomas Ebensen, Simon Delandre, Blair Prochnow, et al.
Current Topics in Medicinal Chemistry|September 27, 2013
Vaccine adjuvants: key tools for innovative vaccine designPeggy Riese, Kai Schulze, Thomas Ebensen, et al.
Clinical and Vaccine Immunology : CVI|June 15, 2007
The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvantThomas Ebensen, Kai Schulze, Peggy Riese, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 6, 2017
Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in miceKai Schulze, Thomas Ebensen, Lorne A Babiuk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Characterization of a B220+ lymphoid cell subpopulation with immune modulatory functions in nasal-associated lymphoid tissuesFaiza Rharbaoui, Dunja Bruder, Melita Vidakovic, et al.
Pageof 8